Table 2.
Relevant miRNA in AGE/RAGE.
miRNAs | Tissue/organ/cell line | Source | Target | Functions | Reference |
---|---|---|---|---|---|
miR-30 family | Podocyte | Mice | AGER, Vim, HSP20, Ier3 | Podocyte homeostasis and podocytopathies | [40] |
| |||||
miR-16 | THP-1 monocytic cells | Human | COX-2 | Regulate inflammation | [41] |
| |||||
miR-214 | THP-1 monocytic cells | Human | PTEN | Monocyte survival | [42] |
| |||||
miR-221/222 | VSMCs | Rat | p27Kip1 and p57Kip2 | Cell proliferation | [44] |
| |||||
miR-221/222 | Endothelial cells | Human | p27Kip1 and p57Kip2 | Cell proliferation | [45] |
| |||||
miR-21 and miR-221 | MES 13 mesangial cells | Mice | Timp3 | DN progression | [46] |
miR-21 | Kidney | Human | |||
| |||||
miR-221/miR-222 | HUVECs | Human | c-Kit | Reduced EC migration | [48] |
AGE: advanced glycation end-product; AGER: advanced glycosylation end-product-specific receptor; c-kit: V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; COX: Cyclooxygenase; DN: diabetic nephropathy; EC: endothelial cells; HSP: Heat shock protein; HUVECs: human umbilical vein endothelial cells; Ier3: immediate early response 3; p27Kip1: Cyclin-Dependent Kinase Inhibitor 1B; p57Kip2: Cyclin-Dependent Kinase Inhibitor 1C; PTEN: phosphatase and tensin homolog; RAGE: Receptor for AGE; Timp: metallopeptidase inhibitor; Vim: Vimentin; VSMCs: vascular smooth muscle cells.